Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pandox in connection with a directed share issue of SEK 2 billion
Mandate

Vinge has advised Pandox in connection with a directed share issue of SEK 2 billion

September 18, 2024

Vinge has advised the hotel property owner Pandox Aktiebolag (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 2 billion before transaction costs.

The company intends to use the proceeds to maintain the company’s strong financial position following hotel acquisitions in London and Edinburgh and to increase the company’s financial flexibility for additional property acquisitions and investments in existing properties. The Pandox share is listed on Nasdaq Stockholm.

Vinge’s team consisted of Jesper Schönbeck, Joel Magnusson, Adrian Filipovic and Maximilian Bengtsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

 Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026